The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Covexin 10 Suspension for injection for sheep and cattle

. Suspension for injection

Zoetis Belgium S.A.VPA10387/008/001

Main Information

Trade NameCovexin 10 Suspension for injection for sheep and cattle
Active SubstancesC. perfringens type a toxoid (strain cn 1491)
C. perfringens type b toxoid (strain cn 1240)
C. perfringens type c toxoid (strain cn 883)
C. perfringens type d toxoid (strain cn 3688)
C. chauvoei whole culture (strain cn 3796)
C. novyi type b toxoid (strain cn 6120)
C. septicum toxoid (strain cn 368)
C. tetani toxoid (strain cn 3911)
C. sordellii toxoid (strain 831)
C. haemolyticum toxoid (strain cn 3629)
Strength.
Dosage FormSuspension for injection
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/008/001

Group Information

ATC CodeQI02AB01 clostridium
QI04AB01 clostridium
Therapeutic ClassImmunological - Inactivated Vaccine
SpeciesCattle
Sheep

Status

Authorised/WithdrawnAuthorised
Licence Issued09/12/2013
Legal StatusLM: Licensed Merchant as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back